Celyad Oncology SA CLYYF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -85.10% | -83.66% | -53.88% | -57.22% | -86.10% |
| Total Receivables | -6.81% | 2.19% | -0.84% | -8.03% | -23.23% |
| Inventory | -90.45% | -89.55% | -- | -- | -- |
| Prepaid Expenses | -100.65% | -100.70% | -68.83% | -71.08% | -49.26% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -97.96% | -97.59% | 1,754.51% | 1,620.12% | 29.19% |
| Total Current Assets | -65.51% | -62.18% | -39.13% | -43.53% | -68.91% |
|
|
|||||
| Total Current Assets | -65.51% | -62.18% | -39.13% | -43.53% | -68.91% |
| Net Property, Plant & Equipment | -- | -- | -100.00% | -100.00% | -12.20% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -33.18% | -26.83% | -21.01% | -26.85% | -20.07% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -25.63% | -18.45% | -53.07% | -56.47% | -16.99% |
| Total Assets | -60.31% | -56.47% | -50.90% | -54.46% | -51.38% |
|
|
|||||
| Total Accounts Payable | -76.87% | -74.64% | -53.00% | -56.40% | -4.77% |
| Total Accrued Expenses | -64.36% | -60.92% | -3.99% | -10.95% | 22.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -45.57% |
| Total Finance Division Other Current Liabilities | -76.31% | -74.02% | 2.82% | -4.63% | 200.90% |
| Total Other Current Liabilities | -76.31% | -74.02% | 2.82% | -4.63% | 200.90% |
| Total Current Liabilities | -75.67% | -73.32% | -27.55% | -32.80% | 68.72% |
|
|
|||||
| Total Current Liabilities | -75.67% | -73.32% | -27.55% | -32.80% | 68.72% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -0.91% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -96.87% | -96.57% | -99.14% | -99.20% | -25.11% |
| Total Liabilities | -88.18% | -87.04% | -77.58% | -79.20% | 0.66% |
|
|
|||||
| Common Stock & APIC | 8.71% | 19.21% | 27.21% | 18.00% | 9.61% |
| Retained Earnings | 3.59% | -5.72% | -13.15% | -4.96% | -11.56% |
| Treasury Stock & Other | -2.69% | 6.71% | 13.44% | 5.23% | 9.63% |
| Total Common Equity | 139.40% | 143.21% | 440.68% | 401.51% | -204.10% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 139.40% | 143.21% | 440.68% | 401.51% | -204.10% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 139.40% | 143.21% | 440.68% | 401.51% | -204.10% |
|
|
|||||